Trevi Therapeutics Inc (TRVI)

Cash & Equivalents

$54.30M

Quarterly · Period ending: · USD

TRVI logo

TRVI Cash & Equivalents

Latest reported$54.30M
TRVI Quarterly Cash & Equivalents ($22.02M → $54.30M)
High-resolution chart · PNG

TRVI cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
54,302,000
19,412,000
18,914,000
56,869,000
117,058,000
19,374,000
34,097,000
16,052,000
12,963,000
13,811,000
32,397,000
25,965,000
13,752,000
11,651,000
12,589,000
66,574,000
24,698,000
29,113,000
36,830,000
29,318,000
36,425,000
41,570,000
45,001,000
53,293,000
44,180,000
52,640,000
57,313,000
63,515,000
71,387,000
12,946,000
17,165,000
13,534,000
-22,020,000
22,020,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.